industries 
Fierce Pharma
OCTOBER 17, 2023
If there’s one thing a wide swath of industry players can agree on, it’s that the FDA’s drug approval process represents the gold standard for drug regulation. | Influential trade group PhRMA—plus hundreds of drugmakers, leaders and investors—are urging the Supreme Court to overturn a restrictive ruling on the abortion pill mifepristone.
Fierce Pharma
JANUARY 16, 2024
After crowning Keytruda as the first immunotherapy for advanced cervical cancer back in 2021, the FDA has awarded the drug another industry-first designation in an earlier stage of the tumor type. But again, the achievement was not perfect for Merck.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 20, 2023
s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. s drug pricing policy, the pharma industry has secured an improved government spending deal. After blasting the U.K.’s After blasting the U.K.’s
Fierce Pharma
FEBRUARY 1, 2024
Despite litigation and denouncements from the biopharma industry, Medicare price negotiations under the Inflation Reduction Act are rolling on. Despite litigation and denouncements from the biopharma industry, Medicare price negotiations under the Inflation Reduction Act are rolling on.
Advertiser: ZoomInfo
Leveraging research and commentary from industry analysts, this eBook explores how your sales team can get back valuable time by overcoming some pain points with your CRM, such as low adoption rates, integrations, and data quality.
Fierce Pharma
APRIL 25, 2024
Joining a list that recently includes Pfizer, UCB and WuXi AppTec, Takeda Pharmaceuticals is the latest drugmaker to pull out of prominent industry lobbying group the Biotechnology Innovation Organ | The company opted not to renew its Biotechnology Innovation Organization (BIO) membership for its next fiscal year.
Fierce Pharma
JANUARY 10, 2024
In AZ's push to reach industry-leading growth by 2030, confidence is key, chief financial officer Aradhana Sarin said at the J.P. With a late-stage pipeline spanning more than 120 clinical trials and a firm grasp of five major disease areas, AstraZeneca appears confident heading into 2024. | Morgan Healthcare Conference.
Advertiser: ZoomInfo
Multiple industry studies confirm that regardless of industry, revenue, or company size, poor data quality is an epidemic for marketing teams. As frustrating as contact and account data management is, this is still your database – a massive asset to your organization, even if it is rife with holes and inaccurate information.
Advertiser: ZoomInfo
With more access to user reviews, analyst opinion, and industry research, decision-makers are more informed than ever while navigating what is now known as the “buyer’s journey.”. Recent digital transformation has shifted the B2B landscape by ushering in the era of buyer empowerment.
Advertiser: ZoomInfo
Go-to-market teams of every size, in every industry, are grappling with these challenges firsthand. Longer sales cycles. Increasingly discerning buyers. More meetings. Intensifying competition. Economic uncertainty. Thankfully, there’s an answer.
Speaker: Patrick Dempsey and Andrew Erpelding of ZoomInfo
Basic search: Easily search using keywords, job title, location, industry, and more. Find and connect with the right talent to fill roles fast with these tools: More data! We have added 10's of millions of personal emails and mobile records.
Advertiser: ZoomInfo
Leveraging the latest industry research, this eBook highlights the impact of direct dial phone numbers on sales productivity with the goal of empowering reps to have more conversations with prospects, and consequently, schedule more meetings, increase opportunities, and close more business - fast.
Advertiser: ZoomInfo
Leveraging leading industry research from industry analysts, this eBook explores how your sales team can gain back valuable time with the following: Conquering the most difficult pain points in your CRM. The result? Less organization, more confusion, and fewer deals closed.
Expert insights. Personalized for you.
348 
Let's personalize your content